Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
BPC-157 and TB-500 Blend Research: Complementary Pathway Activation in Cell Models The content, articles and product information provided on this website are strictly educational and informational
Optimized volume/price ratio, extended autonomy (several weeks at typical 250-500 mcg dose), final concentration adjustable to protocol (5 mg/ml with 2 ml bacteriostatic, or 2.5 mg/ml with 4 ml for finer dosing)
The Wolverine Stack Composition & Key Research Facts Components: BPC-157 (pentadecapeptide, 15 amino acids) and TB-500 (Thymosin Beta-4 fragment) Research designation: Widely referred to as the Wolverine Stack in the pre-clinical peptide research community BPC-157 primary mechanism: VEGFR2/ERK1/2 activation, nitric oxide signalling, fibroblast migration, angiogenesis, ECM stabilisation TB-500 primary mechanism: G-actin sequestration, cytoskeletal reorganisation, keratinocyte and endothelial cell migration, stem/progenitor cell mobilisation Synergy mechanism: BPC-157 organises and vascularises tissue
TB-500 Reconstitution: The Math Behind the Vial TB-500 arrives from the 503A compounding pharmacy as a lyophilized (freeze-dried) powder in a sealed vial
The highest rating was for Nutrilite (96%), a direct sales brand
It directly stimulates keratinocyte proliferation
